Literature DB >> 20593300

Production and single-step purification of Brugia malayi abundant larval transcript (ALT-2) using hydrophobic interaction chromatography.

Surianarayanan Bhuvanesh1, Chakkaravarthi Arunkumar, Perumal Kaliraj, Subramanian Ramalingam.   

Abstract

Abundant larval transcript (ALT), a novel filarial protein, has been shown to have great potential as a vaccine in the prevention of human lymphatic filariasis. In this study, we report a method for the production of recombinant ALT-2 protein, expressed in the cytoplasm of bacterium Escherichia coli in soluble form and purification in a single step using hydrophobic interaction chromatography (HIC). Fermentation was done by continuous fed-batch methodology with dissolved oxygen (DO)-controlled feed addition. The culture was induced with 1 mM isopropyl-β-D: -thiogalactopyranoside (IPTG). Up to 9 g/l dry cell weight (DCW) of biomass was obtained from 1.6 l of Luria-Bertani (LB) broth in a bench-scale reactor. Around 200 mg/l of purified ALT-2 with a yield of about 60% was obtained. This is almost a 2.5-fold increase in final protein yield compared to purification using immobilized metal affinity chromatography (IMAC).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20593300     DOI: 10.1007/s10295-010-0753-2

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  23 in total

1.  A recombinant lipoprotein antigen against Lyme disease expressed in E. coli: fermentor operating strategies for improved yield.

Authors:  R D Madurawe; T E Chase; E I Tsao; W E Bentley
Journal:  Biotechnol Prog       Date:  2000 Jul-Aug

2.  The larval specific lymphatic filarial ALT-2: induction of protection using protein or DNA vaccination.

Authors:  Sabarinathan Ramachandran; Mishra Pankaj Kumar; Reddy Maryada Venkata Rami; Harinath Basker Chinnaiah; Thomas Nutman; Perumal Kaliraj; James McCarthy
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

Review 3.  Making the most of affinity tags.

Authors:  David S Waugh
Journal:  Trends Biotechnol       Date:  2005-06       Impact factor: 19.536

4.  Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.

Authors:  Uma Vanam; Vivek Pandey; Prince R Prabhu; Gajalakshmi Dakshinamurthy; Maryada Venkata Rami Reddy; Perumal Kaliraj
Journal:  Am J Trop Med Hyg       Date:  2009-02       Impact factor: 2.345

5.  Metabolic approaches for the optimisation of recombinant fermentation processes.

Authors:  M Cserjan-Puschmann; W Kramer; E Duerrschmid; G Striedner; K Bayer
Journal:  Appl Microbiol Biotechnol       Date:  1999-12       Impact factor: 4.813

6.  The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.

Authors:  W F Gregory; A K Atmadja; J E Allen; R M Maizels
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 7.  Immune evasion genes from filarial nematodes.

Authors:  R M Maizels; N Gomez-Escobar; W F Gregory; J Murray; X Zang
Journal:  Int J Parasitol       Date:  2001-07       Impact factor: 3.981

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Optimization for a recombinant E. coli fed-batch fermentation.

Authors:  Q Chen; W E Bentley; W A Weigand
Journal:  Appl Biochem Biotechnol       Date:  1995       Impact factor: 2.926

10.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

View more
  5 in total

1.  Immunogenicity of Brugia malayi Abundant Larval Transcript-2, a potential filarial vaccine candidate expressed in tobacco.

Authors:  Mathangi Ganapathy; Adhiseshan Perumal; Chakravarthi Mohan; Harunipriya Palaniswamy; Kaliraj Perumal
Journal:  Plant Cell Rep       Date:  2013-11-07       Impact factor: 4.570

2.  Production of recombinant nonstructural 1 protein in Escherichia coli for early detection of Japanese encephalitis virus infection.

Authors:  Nagesh K Tripathi; Jyoti S Kumar; Karttik C Biswal; P V Lakshmana Rao
Journal:  Microb Biotechnol       Date:  2012-03-27       Impact factor: 5.813

Review 3.  Sophisticated Cloning, Fermentation, and Purification Technologies for an Enhanced Therapeutic Protein Production: A Review.

Authors:  Sanjeev K Gupta; Pratyoosh Shukla
Journal:  Front Pharmacol       Date:  2017-07-04       Impact factor: 5.810

4.  Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus.

Authors:  Amrita Saha; Badri Narayan Acharya; Raj Priya; Nagesh K Tripathi; Ambuj Shrivastava; M Kameswara Rao; Pooja Kesari; Manju Narwal; Shailly Tomar; Sameer S Bhagyawant; Manmohan Parida; Paban Kumar Dash
Journal:  Sci Rep       Date:  2018-07-17       Impact factor: 4.379

5.  Dissolved-oxygen feedback control fermentation for enhancing β-carotene in engineered Yarrowia lipolytica.

Authors:  Peng Jun Lv; Shan Qiang; Liang Liu; Ching Yuan Hu; Yong Hong Meng
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.